Search research articles
Contact Us
Filters
Showing results (411-420 of 466) with videos related to
Page
of 47
Sort By:
Breast Cancer Research : BCR
|
March 25, 2009
TLE3 as a candidate biomarker of response to taxane therapy
Swati A Kulkarni, David G Hicks, Nancy L Watroba, et al.
Breast Cancer : Basic and Clinical Research
|
January 20, 2012
Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients
Ji-Ping Qi, You-Lin Yang, Hong Zhu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 19, 2014
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue
Veronique M Neumeister, Fabio Parisi, Allison M England, et al.
The Review of Scientific Instruments
|
December 3, 2008
Design of a streaked radiography instrument for ICF ablator tuning measurements
R E Olson, D G Hicks, B K Spears, et al.
Nature Cell Biology
|
October 25, 2011
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Yong Jin Choi, Chao-Po Lin, Jaclyn J Ho, et al.
Physical Review Letters
|
August 27, 2013
Solid iron compressed up to 560 GPa
Y Ping, F Coppari, D G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2006
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
Brian Z Ring, Robert S Seitz, Rod Beck, et al.
The Breast Journal
|
February 27, 2007
The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study
Sarah M Short, Brian J Yoder, Shannon M Tarr, et al.
The American Journal of Surgical Pathology
|
August 26, 2006
Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR
David G Hicks, Sarah M Short, Nichole L Prescott, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 1, 2007
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility
William C Powell, David G Hicks, Nichole Prescott, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 466) with videos related to
Sort By:
Page
of 47
Breast Cancer Research : BCR
|
March 25, 2009
TLE3 as a candidate biomarker of response to taxane therapy
Swati A Kulkarni, David G Hicks, Nancy L Watroba, et al.
Breast Cancer : Basic and Clinical Research
|
January 20, 2012
Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients
Ji-Ping Qi, You-Lin Yang, Hong Zhu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 19, 2014
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue
Veronique M Neumeister, Fabio Parisi, Allison M England, et al.
The Review of Scientific Instruments
|
December 3, 2008
Design of a streaked radiography instrument for ICF ablator tuning measurements
R E Olson, D G Hicks, B K Spears, et al.
Nature Cell Biology
|
October 25, 2011
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Yong Jin Choi, Chao-Po Lin, Jaclyn J Ho, et al.
Physical Review Letters
|
August 27, 2013
Solid iron compressed up to 560 GPa
Y Ping, F Coppari, D G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2006
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
Brian Z Ring, Robert S Seitz, Rod Beck, et al.
The Breast Journal
|
February 27, 2007
The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study
Sarah M Short, Brian J Yoder, Shannon M Tarr, et al.
The American Journal of Surgical Pathology
|
August 26, 2006
Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR
David G Hicks, Sarah M Short, Nichole L Prescott, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 1, 2007
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility
William C Powell, David G Hicks, Nichole Prescott, et al.
Page
of 47